Qualitative Analysis of Subject Experience of Nasal Polyps

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Nasal Polyps
Interventions
OTHER

VAS questionnaire

VAS questionnaire is a PRO tool in which subjects will be asked to evaluate overall symptom severity, or the severity of individual symptoms of nasal polyps along a continuum, typically of 10 centimeter (cm) or 100 millimeter (mm) whereby 0 represents 'no symptom' and '10 or 100 represents 'as bad as you can imagine', Scores of 0-3 (or 0-30) are defined as mild disease, \>3-7 (or \>30-70) as moderate disease and \>7-10 (or \>70-100) as severe disease.

OTHER

SNOT-22 questionnaire

SNOT-22 is a PRO tool to measure HRQoL associated with rhinosinusitis with or without nasal polyps. It contains 22 nose, sinus, and general HRQoL items and subjects will be required to score the experience on a 6-point scale ranging from 0 (no problem) to 5 (Problem as bad as it can be) and identify the five most important items affecting their health.

OTHER

Data capture app

Real time data capture app is a smart-phone or web-based application which will allow the subjects to communicate about their experience of nasal polyps in real-time as they go about their daily lives via varying video, audio, photographic and text responses.

Trial Locations (1)

02210

GSK Investigational Site, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT03221192 - Qualitative Analysis of Subject Experience of Nasal Polyps | Biotech Hunter | Biotech Hunter